Vitiligo is a long-term skin disease in which patches of the skin lose their color. The skin patches affected by the disease Vitiligo become white. This happens because melanocytes within the skin die off. The skin pigmentation, melanin, due to which skin has its color, protection from sun UV rays this all happens because of melanocytes cells. Growing per capita healthcare expenditure, improving healthcare infrastructure in developing countries, growing diseases awareness and expected approval of Vitiligo drugs are some of the driving force for the growth of this market. However, shortage of dermatologists and available treatments having longer duration of times are major challenges for the growth of this market. According to Renub Research global vitiligo market will be US$ 2.4 Billion by the year 2024.
Vitiligo disease prevalence varies between race, regions and countries. It is expected that overall prevalence fall between 1-2 percent of the total population. Although Vitiligo disease can arise at any age, it mostly occurs to young and middle age people. At present globally over 21 Million people has suffered from this diseases. There are number of drugs manufactures working for Vitiligo drugs development across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc. and their Vitiligo drugs development are in various stages.
Request a free sample copy of the report: https://www.renub.com/contactus.php
Renub Research report titled “Global Vitiligo Market, Patients By Countries (United States, United Kingdom, France, Germany, Italy, India, China, Japan), Drugs (ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001) Companies (AXIM Biotechnologies, Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals), Clinical Study, Growth Drivers, Challenges” provides a complete analysis of global vitiligo drugs market.
India and China are Key Contributors in the Global Vitiligo Patient Population
Vitiligo patient’s population is growing across all parts of the world. Patient’s growth rates varies in the countries covered in the report United States, United Kingdom, France, Germany, Italy, India, China and Japan. India and China are key contributors in the global vitiligo patient population.
Vitiligo Pipe Line Drugs are Key Strength for this Market Place
In the global vitiligo market, vitiligo pipe line drugs will play the major role for the growth of this market. At present several drugs such as ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.
Key Drugs Development Companies are working in this Market Place
Key drugs development companies are working in this market place across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc.
Segments – Global Vitiligo Market
• Vitiligo Patients Population• Vitiligo Market
Countries – Global Vitiligo Market
• United States• United Kingdom• France• Germany• Italy• India• China • Japan
Client can Purchase this Report in Sections from below link:
Access full Research: https://www.renub.com/global-vitiligo-market-p.php
Global Vitiligo Market – Drugs Profile Covered
• ARN-4079• ATI-502• AX-1602• BOS-47• CCP-070• Cerdulatinib (RVT-502)• HuABC-2• Abatacept• Topical Ruxolitinib• VLRX-001
Companies Covered
• AXIM Biotechnologies• Incyte Corporation• Bristol-Myers Squibb• Clinuvel Pharmaceuticals
Each Company Covered in this Report has Following Details
• Company Overview• Company Initiatives• Financial Insight
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at [email protected]
Browse Related Report :
Spinal Muscular Atrophy Market
Diabetes Drug Market
Contact Us
Renub Research
Phone:+1-678-302-0700
Email: [email protected]
Key Topics Covered :
1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Global Vitiligo Patient Numbers & Market
4.1 Vitiligo Patients Numbers4.2 Vitiligo Market
5. Share – Global Vitiligo Patient Numbers & Market
5.1 Vitiligo Patient Numbers Share5.2 Vitiligo Market Share
6. United States
6.1 Vitiligo Patient Numbers6.2 Vitiligo Market
7. United Kingdom
7.1 Vitiligo Patient Numbers7.2 Vitiligo Market
8. France
8.1 Vitiligo Patient Numbers8.2 Vitiligo Market
9. Germany
9.1 Vitiligo Patient Numbers9.2 Vitiligo Market
10. Italy
10.1 Vitiligo Patient Numbers10.2 Vitiligo Market
11. India
11.1 Vitiligo Patient Numbers11.2 Vitiligo Market
12. China
12.1 Vitiligo Patient Numbers12.2 Vitiligo Market
13. Japan
13.1 Vitiligo Patient Numbers13.2 Vitiligo Market
14. Vitiligo Pipe Line Drugs
14.1 ARN-407914.2 ATI-50214.3 AX-160214.4 BOS-47514.5 CCP-07014.6 Cerdulatinib (RVT-502)14.7 HuABC-214.8 Abatacept14.9 Topical Ruxolitinib14.10 VLRX-001
15. Clinical Study of Vitiligo Market
16. Growth Drivers
16.1 Growing Importance of Aesthetic Appeal16.2 World Vitiligo Day: Increases Vitiligo Awareness
17. Global Vitiligo Market – Challenges
17.1 Shortage of Dermatologists17.2 Available Treatments are Not Much Effective
18. AXIM Biotechnologies, Inc.
18.1 Company Overview18.2 Initiatives18.3 Financial Insight
19. Incyte Corporation
19.1 Company Overview19.2 Initiatives19.3 Financial Insight
20. Bristol-Myers Squibb
20.1 Company Overview20.2 Initiatives20.3 Financial Insight
21. Clinuvel Pharmaceuticals Ltd
21.1 Company Overview21.2 Company Initiatives21.3 Financial Insight
About Us
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Media ContactCompany Name: Renub ResearchContact Person: Rajat GuptaEmail: Send EmailPhone: 6783020700Address:225 Kristie Ln City: RoswellState: GACountry: United StatesWebsite: www.renub.com/life-science-1-c.php
